CTLA4 and neoplasm: Beyond programmed death-1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), novel immune checkpoint receptors (ICRs) play non-redundant roles in suppressing anti-tumor T cell responses.